Association of metabolic dysfunction-associated fatty liver disease with kidney disease
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Association of metabolic dysfunction-associated fatty liver disease with kidney disease
Authors
Keywords
-
Journal
Nature Reviews Nephrology
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-01-10
DOI
10.1038/s41581-021-00519-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical and Histologic Features of Patients with Biopsy-Proven Metabolic Dysfunction-Associated Fatty Liver Disease
- (2021) Shang-Chin Huang et al. Gut and Liver
- Does the risk of cardiovascular events differ between biopsy-proven NAFLD and MAFLD?
- (2021) Gabriel Tayguara Silveira Guerreiro et al. Hepatology International
- Pathophysiology of diabetic kidney disease: impact of SGLT2 inhibitors
- (2021) Ralph A. DeFronzo et al. Nature Reviews Nephrology
- The HSD17B13 rs72613567 variant is associated with lower levels of albuminuria in patients with biopsy-proven nonalcoholic fatty liver disease
- (2021) Dan-Qin Sun et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Uraemic solutes as therapeutic targets in CKD-associated cardiovascular disease
- (2021) Jonathan D. Ravid et al. Nature Reviews Nephrology
- Association Between Metabolic Associated Fatty Liver Disease and Chronic Kidney Disease: A Cross-Sectional Study from NHANES 2017–2018
- (2021) Yunlei Deng et al. Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- Sodium butyrate supplementation inhibits hepatic steatosis by stimulating liver kinase B1 and insulin-induced gene
- (2021) Ze-Hua Zhao et al. Cellular and Molecular Gastroenterology and Hepatology
- Cardiovascular and renal burdens of metabolic associated fatty liver disease from serial US national surveys, 1999–2016
- (2021) Hao-Jie Zhang et al. CHINESE MEDICAL JOURNAL
- Modelling PNPLA3‐Associated Non‐Alcoholic Fatty Liver Disease Using Human Induced Pluripotent Stem Cells
- (2021) Samantha G. Tilson et al. HEPATOLOGY
- The Emerging Role of Glucagon-like Peptide-1 Receptor Agonists for the Management of NAFLD
- (2021) Chandani Patel Chavez et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Metabolic (dysfunction) associated fatty liver disease: more evidence and a bright future
- (2021) Ting-Yao Wang et al. Hepatobiliary Surgery and Nutrition
- MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease
- (2020) Mohammed Eslam et al. GASTROENTEROLOGY
- PNPLA3 I148M gene variant and Chronic Kidney Disease in Type 2 Diabetic Patients With NAFLD: Clinical and Experimental Findings
- (2020) Alessandro Mantovani et al. LIVER INTERNATIONAL
- Transmembrane 6 superfamily member 2 167K allele improves renal function in children with obesity
- (2020) Pierluigi Marzuillo et al. PEDIATRIC RESEARCH
- A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
- (2020) Mohammed Eslam et al. JOURNAL OF HEPATOLOGY
- The case for evidence-based medicine for the association between hyperuricaemia and CKD
- (2020) Stefanie Steiger et al. Nature Reviews Nephrology
- From NAFLD to MAFLD: Implications of a premature change in terminology
- (2020) Zobair M Younossi et al. HEPATOLOGY
- Concordance of MAFLD and NAFLD diagnostic criteria in “real‐world” data
- (2020) Giovanni Targher LIVER INTERNATIONAL
- Comparison of MAFLD and NAFLD diagnostic criteria in real world
- (2020) Su Lin et al. LIVER INTERNATIONAL
- Prevalence of NASH/NAFLD in people with obesity who are currently classified as metabolically healthy
- (2020) Sébastien Frey et al. Surgery for Obesity and Related Diseases
- Non-alcoholic fatty liver disease and risk of incident diabetes mellitus: an updated meta-analysis of 501 022 adult individuals
- (2020) Alessandro Mantovani et al. GUT
- The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease
- (2020) Mohammed Eslam et al. Hepatology International
- Letter regarding “A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement”
- (2020) Lung-Yi Mak et al. JOURNAL OF HEPATOLOGY
- MAFLD identifies patients with significant hepatic fibrosis better than NAFLD
- (2020) Sakura Yamamura et al. LIVER INTERNATIONAL
- Food as medicine: targeting the uraemic phenotype in chronic kidney disease
- (2020) Denise Mafra et al. Nature Reviews Nephrology
- Organ protection by SGLT2 inhibitors: role of metabolic energy and water conservation
- (2020) Adriana Marton et al. Nature Reviews Nephrology
- Pediatric non-alcoholic fatty liver disease and kidney function: Effect of HSD17B13 variant
- (2020) Anna Di Sessa et al. WORLD JOURNAL OF GASTROENTEROLOGY
- 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2021
- (2020) DIABETES CARE
- Non-alcoholic fatty liver disease and risk of incident chronic kidney disease: an updated meta-analysis
- (2020) Alessandro Mantovani et al. GUT
- Clinical utility of the MAFLD definition
- (2020) Kenneth I. Zheng et al. JOURNAL OF HEPATOLOGY
- Insights into contribution of genetic variants towards the susceptibility of MAFLD revealed by the NMR-based lipoprotein profiling
- (2020) Mingfeng Xia et al. JOURNAL OF HEPATOLOGY
- SGLT2 inhibitors may offer benefit beyond diabetes
- (2020) Amy Kang et al. Nature Reviews Nephrology
- Incretin drugs in diabetic kidney disease: biological mechanisms and clinical evidence
- (2020) Radica Z. Alicic et al. Nature Reviews Nephrology
- A single-letter change in an acronym: signals, reasons, promises, challenges, and steps ahead for moving from NAFLD to MAFLD
- (2020) Yusuf Yilmaz et al. Expert Review of Gastroenterology & Hepatology
- MAFLD and risk of CKD
- (2020) Dan-Qin Sun et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Impact of the New Definition of Metabolic Associated Fatty Liver Disease on the Epidemiology of the Disease
- (2020) Vincent Wai-Sun Wong et al. Clinical Gastroenterology and Hepatology
- Uric acid activates aldose reductase and the polyol pathway for endogenous fructose and fat production causing development of fatty liver in rats
- (2019) Laura G. Sánchez-Lozada et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Increased mortality in non-alcoholic fatty liver disease with chronic kidney disease is explained by metabolic comorbidities
- (2019) Kristina Önnerhag et al. Clinics and Research in Hepatology and Gastroenterology
- Association between PNPLA3rs738409 polymorphism decreased kidney function in postmenopausal type 2 diabetic women with or without non-alcoholic fatty liver disease
- (2019) A. Mantovani et al. DIABETES & METABOLISM
- High Risk of Fatty Liver Disease Amplifies the Alanine Transaminase‐Lowering effect of a HSD 17B13 Variant
- (2019) Helene Gellert‐Kristensen et al. HEPATOLOGY
- The case for uric acid-lowering treatment in patients with hyperuricaemia and CKD
- (2019) Yuka Sato et al. Nature Reviews Nephrology
- Intestinal microbiome and fitness in kidney disease
- (2019) Björn Meijers et al. Nature Reviews Nephrology
- Review of Glucagon‐Like Peptide‐1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus in Patients With Chronic Kidney Disease and Their Renal Effects
- (2019) Lance A. Sloan Journal of Diabetes
- Nonalcoholic fatty liver disease and eGFR levels could be linked by the PNPLA3 I148M polymorphism in children with obesity
- (2019) Pierluigi Marzuillo et al. Pediatric Obesity
- Gender effect of hyperuricemia on the development of nonalcoholic fatty liver disease (NAFLD): A clinical analysis and mechanistic study
- (2019) Keyang Xu et al. BIOMEDICINE & PHARMACOTHERAPY
- Association Between a Polymorphism in MBOAT7 and Chronic Kidney Disease in Patients With Biopsy-confirmed Nonalcoholic Fatty Liver Disease
- (2019) Bo Kyung Koo et al. Clinical Gastroenterology and Hepatology
- Quantitative reduction in short-chain fatty acids, especially butyrate, contributes to the progression of chronic kidney disease
- (2019) Siqi Wang et al. CLINICAL SCIENCE
- Lean NAFLD : A Distinct Entity Shaped by Differential Metabolic Adaptation
- (2019) Fei Chen et al. HEPATOLOGY
- Nonalcoholic Fatty Liver Disease (NAFLD), But not Its Susceptibility Gene Variants, Influences the Decrease of Kidney Function in Overweight/Obese Children
- (2019) Di Costanzo et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Higher liver stiffness scores are associated with early kidney dysfunction in patients with histologically proven non-cirrhotic NAFLD
- (2019) Dan-Qin Sun et al. DIABETES & METABOLISM
- PNPLA3 rs738409 is associated with renal glomerular and tubular injury in NAFLD patients with persistently normal ALT levels
- (2019) Dan‐Qin Sun et al. LIVER INTERNATIONAL
- NAD+ homeostasis in renal health and disease
- (2019) Kenneth M. Ralto et al. Nature Reviews Nephrology
- The gut-liver-kidney axis: Novel regulator of fatty liver associated chronic kidney disease
- (2019) Desh Raj et al. PHARMACOLOGICAL RESEARCH
- Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission
- (2019) Shiv K Sarin et al. Lancet Gastroenterology & Hepatology
- Type and Pattern of Alcohol Consumption is Associated With Liver Fibrosis in Patients With Non-alcoholic Fatty Liver Disease
- (2018) Tim Mitchell et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Bile acid receptors and the kidney
- (2018) Michal Herman-Edelstein et al. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- Nonalcoholic fatty liver disease and albuminuria
- (2018) Karn Wijarnpreecha et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- NAFLD risk alleles in PNPLA3, TM6SF2, GCKR and LYPLAL1 show divergent metabolic effects
- (2018) Eeva Sliz et al. HUMAN MOLECULAR GENETICS
- Advanced liver fibrosis but not steatosis is independently associated with albuminuria in Chinese patients with type 2 diabetes
- (2018) Ming-Wai Yeung et al. JOURNAL OF HEPATOLOGY
- Nonalcoholic fatty liver disease increases risk of incident chronic kidney disease: A systematic review and meta-analysis
- (2018) Alessandro Mantovani et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- The effects of dietary supplementation with inulin and inulin-propionate ester on hepatic steatosis in adults with non-alcoholic fatty liver disease
- (2018) Edward S. Chambers et al. DIABETES OBESITY & METABOLISM
- The global prevalence and genetic spectrum of lysosomal acid lipase deficiency: A rare condition that mimics NAFLD
- (2018) Anna Carter et al. JOURNAL OF HEPATOLOGY
- Chronic kidney disease is independently associated with increased mortality in patients with nonalcoholic fatty liver disease
- (2018) James Paik et al. LIVER INTERNATIONAL
- Promoting genetics in non-alcoholic fatty liver disease: Combined risk score through polymorphisms and clinical variables
- (2018) Umberto Vespasiani-Gentilucci et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in NAFLD
- (2017) Na Jiao et al. GUT
- The PNPLA3 I148M variant modulates the fibrogenic phenotype of human hepatic stellate cells
- (2017) Francesca Virginia Bruschi et al. HEPATOLOGY
- The membrane-bound O-acyltransferase domain-containing 7 variant rs641738 increases inflammation and fibrosis in chronic hepatitis B
- (2017) Khaled Thabet et al. HEPATOLOGY
- Emerging roles of SIRT1 in fatty liver diseases
- (2017) Ren-Bo Ding et al. International Journal of Biological Sciences
- A dual agonist of farnesoid X receptor (FXR) and the G protein–coupled receptor TGR5, INT-767, reverses age-related kidney disease in mice
- (2017) Xiaoxin X. Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD
- (2017) Hannes Hagström et al. JOURNAL OF HEPATOLOGY
- The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent
- (2016) Rosellina Margherita Mancina et al. GASTROENTEROLOGY
- Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes
- (2016) Zobair M. Younossi et al. HEPATOLOGY
- TM6SF2 may drive postprandial lipoprotein cholesterol toxicity away from the vessel walls to the liver in NAFLD
- (2016) Giovanni Musso et al. JOURNAL OF HEPATOLOGY
- Glomerular Diseases Associated With Hepatitis B and C
- (2015) Anu Gupta et al. ADVANCES IN CHRONIC KIDNEY DISEASE
- Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
- (2015) Paul Angulo et al. GASTROENTEROLOGY
- PNPLA3 rs738409 and TM6SF2 rs58542926 gene variants affect renal disease and function in nonalcoholic fatty liver disease
- (2015) Giovanni Musso et al. HEPATOLOGY
- Gut Bacteria Products Prevent AKI Induced by Ischemia-Reperfusion
- (2015) V. Andrade-Oliveira et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Influence of the PNPLA3 rs738409 Polymorphism on Non-Alcoholic Fatty Liver Disease and Renal Function among Normal Weight Subjects
- (2015) Kentaro Oniki et al. PLoS One
- Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease
- (2015) Sanja Stojsavljević WORLD JOURNAL OF GASTROENTEROLOGY
- CKD and Nonalcoholic Fatty Liver Disease
- (2014) Giovanni Targher et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Intestinal permeability is increased in children with non-alcoholic fatty liver disease, and correlates with liver disease severity
- (2014) Valentina Giorgio et al. DIGESTIVE AND LIVER DISEASE
- Gut Bacterial Translocation May Aggravate Microinflammation in Hemodialysis Patients
- (2014) Kehui Shi et al. DIGESTIVE DISEASES AND SCIENCES
- Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults
- (2014) Edward S Chambers et al. GUT
- PNPLA3 has retinyl-palmitate lipase activity in human hepatic stellate cells
- (2014) Carlo Pirazzi et al. HUMAN MOLECULAR GENETICS
- GCK, GCKR polymorphisms and risk of chronic kidney disease in Japanese individuals: data from the J-MICC Study
- (2014) Asahi Hishida et al. JOURNAL OF NEPHROLOGY
- Control of appetite and energy intake by SCFA: what are the potential underlying mechanisms?
- (2014) Edward S. Chambers et al. PROCEEDINGS OF THE NUTRITION SOCIETY
- Association of Non-alcoholic Fatty Liver Disease with Chronic Kidney Disease: A Systematic Review and Meta-analysis
- (2014) Giovanni Musso et al. PLOS MEDICINE
- Metabolic syndrome and chronic kidney disease
- (2013) Ajay K. Singh et al. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- Effect of lifetime alcohol consumption on the histological severity of non-alcoholic fatty liver disease
- (2013) Hellan K. Kwon et al. LIVER INTERNATIONAL
- Renal tubular Sirt1 attenuates diabetic albuminuria by epigenetically suppressing Claudin-1 overexpression in podocytes
- (2013) Kazuhiro Hasegawa et al. NATURE MEDICINE
- Olfactory receptor responding to gut microbiota-derived signals plays a role in renin secretion and blood pressure regulation
- (2013) Jennifer L. Pluznick et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology
- (2012) Naga Chalasani et al. GASTROENTEROLOGY
- Patatin-like phospholipase domain-containing 3 (PNPLA3) I148M (rs738409) affects hepatic VLDL secretion in humans and in vitro
- (2012) Carlo Pirazzi et al. JOURNAL OF HEPATOLOGY
- Modest alcohol consumption is associated with decreased prevalence of steatohepatitis in patients with non-alcoholic fatty liver disease (NAFLD)
- (2012) Winston Dunn et al. JOURNAL OF HEPATOLOGY
- Association of eGFR-Related Loci Identified by GWAS with Incident CKD and ESRD
- (2011) Carsten A. Böger et al. PLoS Genetics
- The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis
- (2010) Mustafa S. Ascha et al. HEPATOLOGY
- Prevalence, gender, ethnic variations, and prognosis of NASH
- (2010) Etsuko Hashimoto et al. JOURNAL OF GASTROENTEROLOGY
- Mechanisms Linking Obesity, Chronic Kidney Disease, and Fatty Liver Disease: The Roles of Fetuin-A, Adiponectin, and AMPK
- (2010) J. H. Ix et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Microalbuminuria in nondiabetic patients with nonalcoholic fatty liver disease: association with liver fibrosis
- (2010) Yusuf Yilmaz et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Influence of ethnicity on histological differences in non-alcoholic fatty liver disease
- (2009) Smruti R. Mohanty et al. JOURNAL OF HEPATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation